Biocardia earnings were -$7.3M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest BCDA earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$1.6M, down 28.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, BCDA reported annual earnings of -$8.2M, with 3.5% growth. The next BCDA earnings date is Nov 11, 2026.
On BCDA's earnings call on Aug 12, 2026, Biocardia (NASDAQ: BCDA) reported Q2 2026 earnings per share (EPS) of -$0.13, up 67.5% year over year. Total BCDA earnings for the quarter were -$1.61 million. In the same quarter last year, Biocardia's earnings per share (EPS) was -$0.40.
The next BCDA earnings call is Nov 11, 2026. Add BCDA to your watchlist to be reminded of Biocardia's next earnings date.
Is Biocardia profitable or losing money?
As of the last Biocardia earnings report, Biocardia is currently losing money. Biocardia's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$7.34 million, a 16.55% decrease year over year.
What was BCDA's earnings growth in the past year?
As of Biocardia's earnings date in Aug 12, 2026, Biocardia's earnings has grown year over year. BCDA earnings in the past year totalled -$7.34 million.
What are Biocardia's earnings expectations?
The current EPS estimate for Biocardia's earnings report in Nov 11, 2026 is -$0.15.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.